QL
PTCT icon

Quarry LP’s PTC Therapeutics PTCT Stock Holding History

Quarry LP’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.2K Sell
1,250
-2,615
-68% -$185K 0.02% 534
2025
Q4 		$294K Buy
3,865
+3,561
+1,171% +$259K 0.05% 223
2025
Q3 		$18.7K Buy
+304
New +$15.8K ﹤0.01% 1448
2024
Q4 		– Sell
-5,000
Closed -$186K – 1937
2024
Q3 		$186K Hold
5,000
– – 0.05% 250
2024
Q2 		$153K Buy
5,000
+2,500
+100% +$81K 0.04% 219
2024
Q1 		$72.7K Buy
+2,500
New +$70K 0.01% 311

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Quarry LP's PTCT Position: Q1 2026 in Review

Quarry LP reduced its PTC Therapeutics (PTCT) stake by 68% in Q1 2026, selling an estimated $185K and leaving 1,250 shares worth $85.2K. The position accounts for 0.02% of the portfolio, ranked #534.

Quarry LP first reported a position in PTCT in Q1 2024 and has held it in 6 quarters since. The position peaked at $294K in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Quarry LP held 1,250 shares of PTC Therapeutics worth $85.2K as of Q1 2026.
  • Quarry LP sold 2,615 PTC Therapeutics shares in Q1 2026, an estimated $185K.
  • PTC Therapeutics made up 0.02% of Quarry LP's portfolio in Q1 2026, its #534 holding.
  • Quarry LP first reported a position in PTC Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • Quarry LP's PTC Therapeutics position peaked at $294K in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.